Latest Publications

Share:

Europe’s increased focus on the environment and corporate sustainability: an expensive game changer for the pharma industry...

Over the past decade, the European Union has enacted a host of new legislation to protect the environment, promote sustainability, and tackle climate change, including the European Green Deal to new reporting and due...more

Two years on from its launch, how has the UPC impacted European patent litigation in the life sciences sector?

The UPC has been reshaping European patent litigation since its launch in June 2023. More than 480 patents have now been litigated in the court, and the number of actions is steadily increasing. Initially, major...more

UPC: No Liability For Holding Companies Without Active Participation In Patent Infringement

On February 12, 2026, the Düsseldorf Local Division (LD Düsseldorf) of the Unified Patent Court (UPC) granted a preliminary injunction against a number of group companies, including entities based in the Cayman Islands and...more

For Medical Devices, “Possible Use” Amounts To Infringement Only If The Use Is In Line With Medical Practice

Emboline v. AorticLab—UPC_CFI_628/2024, judgment of January 13, 2026 - The UPC Munich Local Division (the LD Munich) has dismissed an infringement action relating to a medical device. It confirmed that a device can still...more

Digital Networks Act And CSA 2.0: Key Implications For Telecoms And Digital Infrastructure

The European Commission (Commission) published a proposal for a new Digital Networks Act (DNA), and a revised Cybersecurity Act, aiming to reshape the EU regulatory framework for digital connectivity, telecoms, and...more

European Commission announces new Cybersecurity Package, including proposed amendments to the Cybersecurity Act

On January 20 2026, the European Commission announced its new cybersecurity package which aims to strengthen the EU’s cybersecurity resilience in response to an evolving threat landscape....more

European Commission Announces Digital Omnibus Proposal

On November 19 2025, the European Commission presented the Digital Omnibus Package (the Package). The Package contains the following three proposals for regulations on: (i) the simplification of the digital acquis...more

UPC: CE Marking For A Medical Device As A Trigger For “Imminent Infringement”, Refining The Standard On Imminence, Urgency, And...

The UPC has granted a preliminary injunction effective for Germany, France, Italy, the Netherlands and Ireland against a Chinese medical device manufacturer and its Dutch subsidiary over the infringement of a patent for...more

Europe’s Increased Focus On The Environment And Corporate Sustainability: An Expensive Game Changer For The Pharma Industry

Over the past decade, the European Union has enacted a host of new legislation to protect the environment, promote sustainability and tackle climate change, ranging from the European Green Deal to new reporting and due...more

The EDPB adopts two opinions on the Commission’s draft decisions extending the UK’s adequacy decisions under the GDPR and LED

On October 20 2025, the European Data Protection Board (EDPB) announced that it had adopted two opinions on the European Commission’s draft implementing decisions which propose to extend the validity of the UK adequacy...more

UPC Court of Appeal Clarifies Rules on Directors’ Liability for Patent Infringement

The UPC Court of Appeal (the CoA) has issued a significant judgment in Koninklijke Philips v. Belkin clarifying the scope of directors’ liability. The court also confirmed the availability of corrective measures such as...more

Belgian Competition Authority Issues Guidance on Information Exchange Between Pharmaceutical Companies for Combination Therapies

On 10 September 2025, the Belgian Competition Authority (the BCA) published a communication clarifying the conditions under which pharmaceutical companies may exchange information specifically in the context of reimbursement...more

Life Sciences and Healthcare Insights

Welcome to our inaugural Life sciences and healthcare insights report, where our global team share their insights on the most important commercial, legal, and regulatory issues facing life sciences and healthcare companies...more

Historic UPC Court of Appeal Decision Changes the Landscape for European Generics

In a landmark ruling the UPC Court of Appeal has for the first time in the pharmaceutical sector granted a provisional injunction for imminent patent infringement, clarifying that completing administrative procedures for...more

A new European strategy to foster life sciences innovation and market access

On July 2, 2025, the European Commission released its communication “Choose Europe for life sciences. A strategy to position the EU as the world’s most attractive place for life sciences by 2030” (the Strategy). ...more

The European Commission publishes its AI Continent Action Plan

On April 9 2025, the European Commission published the AI Continent Action Plan (the Action Plan), which outlines the EU’s strategy to enhance innovation, competitiveness and regulatory compliance in artificial intelligence...more

EC publishes draft delegated regulation on subcontracting RTS under DORA

On March 24 2025, the European Commission (EC) adopted the final draft Delegated Regulation setting out Regulatory Technical Standards (RTS) for subcontracting ICT services supporting critical or important functions under the...more

European Health Data Space Regulation sets requirements for electronic health record systems

On March 5, 2025, Regulation (EU) 2025/327 of the European Parliament and of the Council of February 11, 2025 on the European Health Data Space and amending Directive 2011/24/EU and Regulation (EU) 2024/2847 (the Regulation)...more

EU Commission announces intention to withdraw AI Liability Directive and ePrivacy

On February 11 2025, the European Commission (the EU Commission) released its 2025 work programme in which it published its AI and privacy initiatives for 2025 (the Work Programme) in order to boost competitiveness, enhance...more

Zooming in on AI – #13: EU AI act– Focus on fundamental rights impact assessment for high-risk AI systems

Companies deploying high-risk artificial intelligence (AI) systems must prepare to conduct Fundamental Rights Impact Assessment (FRIA) by 2 August 2026. In this edition of our “Zooming in on AI” series we explain what this...more

Zooming in on AI – #12: Spotlight on GPAI Models

When the AI Act was first proposed by the European Commission in 2021, the concept of “general purpose AI” was nowhere to be found. These rules were introduced during the legislative process to align the AI Act to the...more

Council approves EU AI Act

Highlight of the week - On 21 May 2024, the Council of the European Union (the Council) issued a press release announcing it had approved the Proposal for a Regulation of the European Parliament and of the Council Laying Down...more

UPC Insights: Security for legal costs

The UPC decides that the defendant’s financial situation and location matter. On 30 October 2023, the Munich Central Division of the UPC (the Court) issued an order stating that NanoString must provide security to Harvard...more

Compromise reached on the Artificial Intelligence Act

The European Parliament (the Parliament) and the Council of the European Union (the Council) reached a compromise on the Artificial Intelligence Act (the AI Act) on 8 December 2023. Although the final text is not yet...more

36 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide